Ophthalmic

leading cause of blindness worldwide

leading cause of blindness in elderly in US

progressive, painless clouding of the eye

cataracts risk factors

blurry vision, seeing double, light sensitivity, trouble sleeping, seeing bright colors as faded or yellow instead

cataracts treatment

NLO

AMD

progressive deterioration of critical region of retina

AMD pathogenesis

AMD risk factors

optic drusen, slow loss over time of central vision, cannot see fine details, peripheral visions remains normal

____ has dry and wet forms

macula gets thinner with yellow deposits of drusen

most common form of AMD

dry AMD treatment

growth of abnormal blood vessels from choroid

vitamins and antioxidants may help with

wet AMD treatments

ranibizumab

pegaptanib

aflibercept

brolucizumab

aka pink eye

dilation of vessels, hyperemia, discharge, redness, burning, itching, blurriness, light sensitivity

types of conjunctivitis

types of infectious conjunctivitis

types of noninfectious conjunctivitis

which type of infectious conjunctivitis is more common

treatment of viral conjunctivitis

treatment of bacterial conjunctivitis

non-infectious conjunctivitis is primarily

treatment of non-infectious conjunctivitis

DES

causes of DES

types of tears

tears that are produced continuously and are natural antibiotics

tears that are released in response to something

risk factors DES

redness, stinging, scratching, burning, light sensitivity, watery eyes, blurry eyes

treatment options for dry eye syndrome

cyclosporine MOA in DES

liftegrast MOA in DES

what to avoid in DES

dry, watery, red, proptosis, diplopia, difficulty closing eyes

TED

TED treatment

teprotumumab MOA

teprotumumab ADR

xiidra ADR (liftegrast)